Zobrazeno 1 - 10
of 17 186
pro vyhledávání: '"oral-anticoagulants"'
Autor:
Jørgensen CM, Boe NJ, Hald SM, Meyer-Kristensen F, Norlén MM, Ovesen C, Möller S, Høyer BB, Bojsen JA, Elhakim MT, Harbo FSG, Al-Shahi Salman R, Goldstein LB, Hallas J, García Rodríguez LA, Selim M, Gaist D
Publikováno v:
Clinical Epidemiology, Vol Volume 16, Pp 837-848 (2024)
Christian Mistegård Jørgensen,1 Nils Jensen Boe,1 Stine Munk Hald,1 Frederik Meyer-Kristensen,1 Mie Micheelsen Norlén,1 Christian Ovesen,1,2 Sören Möller,3,4 Birgit Bjerre Høyer,3 Jonas Asgaard Bojsen,5 Mohammad Talal Elhakim,5 Frederik Severin
Externí odkaz:
https://doaj.org/article/cf0cab2ed20b4fc7804620ba897e43b9
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 20, Iss 5, Pp 514-524 (2024)
Aim. To analyze published clinical trials to evaluate the safety and effectiveness of direct oral anticoagulants in comparison with warfarin in a population of patients with atrial fibrillation and chronic kidney disease stages C4-C5.Material and met
Externí odkaz:
https://doaj.org/article/3a14ea7eb3704c04b88c4f752fc05649
Publikováno v:
BMC Chemistry, Vol 18, Iss 1, Pp 1-21 (2024)
Abstract This study reveals one-step green synthesis of plant inspired silver nanoparticles (Ag-NPs). The synthesis procedure relies on the bio-reduction of Ag+ to Ag0 using orange waste (orange peel) extract as cheap, readily available, sustainable,
Externí odkaz:
https://doaj.org/article/494d643a0c7849f8b064f9ee1d39b325
Autor:
Alina Doina Nicoara, Andra Iulia Suceveanu, Ionut Eduard Iordache, Iulia Tania Andronache, Andreea Nelson Twakor, Andreea Georgiana Sunda, Ioan Cristian Nichita, Anca Pantea Stoian, Felix Voinea, Adrian Paul Suceveanu
Publikováno v:
Journal of Mind and Medical Sciences, Vol 11, Iss 2, Pp 363-373 (2024)
Managing anticoagulation therapy in individuals with atrial fibrillation who also have liver disease is highly challenging due to altered blood clotting processes and the risk of bleeding due to liver dysfunction. The literature highlights the comple
Externí odkaz:
https://doaj.org/article/93187e758bfe486db9f1bad8e49968ab
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 20, Iss 4, Pp 460-467 (2024)
The Beers Criteria are a tool for optimizing pharmacotherapy in elderly patients, containing information on potentially inappropriate drugs, which is only advisory in nature and is not mandatory for use in Russian Federation. In the updated version o
Externí odkaz:
https://doaj.org/article/802cbd04defc492d93b88c6ca7a71540
Autor:
A. V. Ponomarenko, A. D. Gavrilko, A. A. Gartung, M. S. Poliakova, A. A. Oganesyan, K. S. Benimetskaya, D. V. Losik, S. V. Shalaev
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 20, Iss 4, Pp 468-477 (2024)
Cardiology, like other branches of medicine, is increasingly faced with the need not only to optimize patient treatment, reduce financial costs, but also to improve long-term outcomes. The volume of information required for such tasks is significant,
Externí odkaz:
https://doaj.org/article/e337a0729752491c9a2f1ee3dca993d8
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 16, Iss 4, Pp 111-121 (2024)
Every third or fourth ischemic stroke is cardioembolic. Prescribing oral anticoagulants can significantly reduce the risk of recurrent stroke, but this strategy requires the physician to have a firm orientation in the “efficacy – safety” coordi
Externí odkaz:
https://doaj.org/article/56e30f82e78c4ab28fa6ebc05895e54e
Publikováno v:
BMC Cardiovascular Disorders, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background The objective of this study is to investigate the incidence, potential risk factors, and clinical outcomes of incomplete device endothelialization (IDE) in atrial fibrillation (AF) patients undergoing Watchman left atrial appendag
Externí odkaz:
https://doaj.org/article/b71f721fed934381891b8f18e3d252f5
Autor:
Ian Eustace
Publikováno v:
Cerebrovascular Diseases Extra, Vol 14, Iss 1, Pp 101-104 (2024)
Externí odkaz:
https://doaj.org/article/00fdac6352074a95990f824230860a41
Autor:
Paisit Kosum, Noppachai Siranart, Kunathip Nissaipan, Wattakorn Laohapiboolrattana, Walit Sowalertrat, Kanittha Triamamornwooth, Rawiwan Arunphan, Apiradee Sriyom, Voravut Rungpradubvong
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Warfarin remains the most prescribed oral anticoagulant of choice in atrial fibrillation (AF) patient in resource-limited settings. Despite evidence linking Time in Therapeutic Range (TTR) to patient outcomes, its use in clinical practice is
Externí odkaz:
https://doaj.org/article/3fa8885d8cc14adfb51741c69c0dfa2b